Du har inte javascript påslaget. Det innebär att många funktioner inte fungerar. För mer information om Vinnova, ta kontakt med oss.

E!10253, CD-CARD, Diagnostic product for rapid HIV-patient testing, Getica AB

Diarienummer
Koordinator GETICA AB - Sahlgrenska Science Park
Bidrag från Vinnova 4 615 388 kronor
Projektets löptid mars 2016 - augusti 2019
Status Avslutat
Utlysning Eurostars – för forskande små och medelstora företag

Syfte och mål

Measurements of CD4 receptors on the surface og lymphocytes in whole blood samples by means of flow cytometry technology is the classical method for monitoring treatment of HIV infected patients. The reagent and the equipment are expensive, and may patiens do not have access to the technologies. Getica AB has - in collaboration with Gentian AS in Norway , with Oslo University Hospital and Sahlgrenska University Hospital, developed a near patient method for said monitoring, faster and less expensive than the flow cytometry reference method.

Resultat och förväntade effekter

The project resulted in a successful calibration study in Gothenburg and successful measurements of the concentration of the concentration of the CD4 receptors in 50 patients treated for HIV infections at Oslo University Hospital. The project will will constitute the basis for optimasasion studies and adapting the methods to commercial products to be produced in Gothenburg.

Upplägg och genomförande

Oslo and Västra Götaland has well developed programs for monitoring and treatment of HIV patiens, and the result of the treatment and monitoring the patients have lead to improved prognosis for the patients. Further collaboration with the partners will lead to further commercial development of the assay technology and sales to the testing laboratories internationally.

Texten på den här sidan har projektgruppen själv formulerat. Innehållet är inte granskat av våra redaktörer.

Senast uppdaterad 8 maj 2017

Diarienummer 2016-01012

Statistik för sidan